Literature DB >> 12705343

Quality assurance for cerebrospinal fluid protein analysis: international consensus by an Internet-based group discussion.

Hansotto Reiber1, Edward J Thompson, Guy Grimsley, Gaetano Bernardi, Pavel Adam, Sergio Monteiro de Almeida, Pam Fredman, Geoffrey Keir, Manfred Lammers, Roland Liblau, Marcio Menna-Barreto, Maria José Sá, Erika Seres, Christian J M Sindic, Albert Teelken, Christian Trendelenburg, María Trojano, Marie-Paule van Antwerpen, Marcel M Verbeek.   

Abstract

A group of neurologists and clinical neurochemists representing twelve countries worked towards a consensus on laboratory techniques to improve the quality of analysis and interpretation of cerebrospinal fluid (CSF) proteins. Consensus was approached via a virtual Lotus Notes-based TeamRoom. This new approach respecting multicultural differences, common views, and minority opinions, is available in http://www.teamspace.net/ CSF, presenting the implicit, complementary version of this explicit, printed consensus. Three key recommendations were made: CSF and (appropriately diluted) serum samples should be analyzed together in one analytical run, i.e., with reference to the same calibration curve. Results are evaluated as CSF/serum quotients, taking into account the non-linear, hyperbolic relation between immunoglobulin (Ig)- and albumin-quotients rather than using the linear IgG index or IgG synthesis rate. Controls should include materials with values within the reference ranges (IgM: 0.5-1.5 mg/l; IgA: 1-3 mg/l; IgG: 10-30 mg/l and albumin: 100-300 mg/l). The physiological, methodological and clinical significance of CSF/serum quotients is reviewed. We confirmed the previous consensus on oligoclonal IgG, in particular the usefulness of the five typical interpretation patterns. The group compared current external and internal quality assurance schemes and encouraged all members to maintain national or local traditions. Values for acceptable imprecision in the CSF quality assurance are proposed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12705343     DOI: 10.1515/CCLM.2003.053

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  15 in total

Review 1.  Inflammatory and autoimmune diseases of the nervous system; possibilities of laboratory diagnostic methods in cerebrospinal fluid.

Authors:  Z Lodin
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Critical evaluation of the biological role of IgM in cerebrospinal fluid in inflammatory and other diseases of the nervous system.

Authors:  J Svatonová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

3.  Cerebrospinal-fluid profile in neuroborreliosis and its diagnostic significance.

Authors:  J Bednárova
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

4.  Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics.

Authors:  Sergio M de Almeida; Michelli F Oliveira; Antoine Chaillon; Indianara Rotta; Clea E Ribeiro; Ana Paula de Pereira; Davey Smith; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2018-09-07       Impact factor: 2.643

5.  Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children.

Authors:  Svenja Kristin Kunert; Hans Hartmann; Dieter Haffner; Maren Leifheit-Nestler
Journal:  J Bone Miner Metab       Date:  2016-03-26       Impact factor: 2.626

6.  The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).

Authors:  Johannes Brettschneider; Anne Czerwoniak; Makbule Senel; Lubin Fang; Jan Kassubek; Elmar Pinkhardt; Florian Lauda; Tamara Kapfer; Sarah Jesse; Vera Lehmensiek; Albert C Ludolph; Markus Otto; Hayrettin Tumani
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

7.  Brain microdialysis as a tool to explore the ionic profile of the brain extracellular space in neurocritical patients: a methodological approach and feasibility study.

Authors:  Tamara Martínez-Valverde; Marian Vidal-Jorge; Noelia Montoya; Angela Sánchez-Guerrero; Susana Manrique; Francisca Munar; Maria-Dolors Pellegri; Maria-Antonia Poca; Juan Sahuquillo
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

8.  Cerebrospinal fluid and serum prealbumin (transthyretin) in patients with multiple sclerosis (MS): comparison of particular subgroups of MS patients.

Authors:  M Hybelová; J Svatonová; O Sobek; P Adam; D Dolezil; D Adam
Journal:  Folia Microbiol (Praha)       Date:  2009-05-06       Impact factor: 2.099

9.  IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome.

Authors:  Johannes Brettschneider; Hayrettin Tumani; Ulrike Kiechle; Rainer Muche; Gayle Richards; Vera Lehmensiek; Albert C Ludolph; Markus Otto
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

10.  Coefficient of energy balance: effective tool for early differential diagnosis of CNS diseases.

Authors:  Klára Bořecká; Pavel Adam; Ondřej Sobek; Lenka Hajduková; Věra Lánská; Petr Nekola
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.